{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:30:43Z","timestamp":1770910243570,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":5213,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1111\/j.1538-7836.2008.03065.x","type":"journal-article","created":{"date-parts":[[2008,7,5]],"date-time":"2008-07-05T21:31:23Z","timestamp":1215293483000},"page":"1525-1533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Activity and regulation of glycoPEGylated factor\u00a0VIIa analogs"],"prefix":"10.1016","volume":"6","author":[{"given":"S.","family":"GHOSH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"SEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.R.","family":"PENDURTHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.V.M.","family":"RAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl.","key":"10.1111\/j.1538-7836.2008.03065.x_bb0010","first-page":"S147","article-title":"Recombinant activated factor\u00a0VII as a universal haemostatic agent","volume":"9","author":"Hedner","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0015","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2004-06-2223","article-title":"The use of recombinant factor\u00a0VIIa in the treatment of bleeding disorders","volume":"104","author":"Roberts","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0020","first-page":"112","article-title":"Potential role of recombinant factor\u00a0VIIa as a hemostatic agent","volume":"1","author":"Hedner","year":"2003","journal-title":"Clin Adv Hematol Oncol"},{"issue":"Suppl.","key":"10.1111\/j.1538-7836.2008.03065.x_bb0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/ort.1965.36.suppl-77.01","article-title":"Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculo\u2010skeletal manifestations of haemophilia\u00a0A and B","volume":"77","author":"Ahlberg","year":"1965","journal-title":"Acta Orthop Scand Suppl"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.1992.tb00546.x","article-title":"Twenty\u2010five years\u2019 experience of prophylactic treatment in severe haemophilia\u00a0A and B","volume":"232","author":"Nilsson","year":"1992","journal-title":"J Intern Med"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0035","first-page":"111","article-title":"Our experience in Sweden with prophylaxis on haemophilia","volume":"34","author":"Nilsson","year":"1970","journal-title":"Bibl Haematol"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2008.03065.x_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2516.9.s1.17.x","article-title":"Consensus perspectives on prophylactic therapy for haemophilia: summary statement","volume":"9","author":"Berntorp","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0045","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2516.2007.01455.x","article-title":"Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor\u00a0VIIa in European Haemophilia Centres","volume":"13","author":"Morfini","year":"2007","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0050","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/j.1538-7836.2007.02663.x","article-title":"Randomized, prospective clinical trial of recombinant factor\u00a0VIIa for secondary prophylaxis in hemophilia patients with inhibitors","volume":"5","author":"Konkle","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0055","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/clpt.1994.80","article-title":"Pharmacokinetics and pharmacodynamics of recombinant factor\u00a0VIIa","volume":"55","author":"Lindley","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00003088-200140070-00005","article-title":"Pegylation: a novel process for modifying pharmacokinetics","volume":"40","author":"Harris","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0070","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10717540600814402","article-title":"Pharmacokinetic consequences of pegylation","volume":"13","author":"Hamidi","year":"2006","journal-title":"Drug Deliv"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0075","doi-asserted-by":"crossref","first-page":"22987","DOI":"10.1016\/S0021-9258(18)50045-4","article-title":"Uptake, intracellular transport, and degradation of polyethylene glycol\u2010modified asialofetuin in hepatocytes","volume":"267","author":"Roseng","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0080","first-page":"1716","article-title":"Binding and functional studies with the growth hormone receptor antagonist, B2036\u2010PEG (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer","volume":"86","author":"Ross","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0085","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1021\/bi00420a030","article-title":"Amino acid sequence and posttranslational modifications of human factor\u00a0VIIa from plasma and transfected baby hamster kidney cells","volume":"27","author":"Thim","year":"1988","journal-title":"Biochemistry"},{"issue":"Suppl.","key":"10.1111\/j.1538-7836.2008.03065.x_bb0090","article-title":"Develeopment of long\u2010acting factor\u00a0VIIa derivatives by glycopegylation","volume":"5","author":"Bayer","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0095","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood.V87.9.3738.bloodjournal8793738","article-title":"Studies of the activation of factor\u00a0VII bound to tissue factor","volume":"87","author":"Rao","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0100","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1021\/bi00507a028","article-title":"Phospholipid vesicle formation and transmembrane protein incorporation using octylglucoside","volume":"20","author":"Mimms","year":"1981","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1055\/s-0038-1649709","article-title":"Importance of substrate composition, pH and other variables on tissue factor enhancement of factor\u00a0VIIa activity","volume":"70","author":"Neuenschwander","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0110","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1055\/s-0037-1615605","article-title":"The role of catalytic cleft and exosite residues of factor\u00a0VIIa for complex formation with tissue factor pathway inhibitor","volume":"85","author":"Iakhiaev","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0115","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1538-7836.2007.02308.x","article-title":"Activity and regulation of factor\u00a0VIIa analogs with increased potency at the endothelial cell surface","volume":"5","author":"Ghosh","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0120","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1042\/BJ20061901","article-title":"Engineering the substrate and inhibitor specificities of human coagulation factor\u00a0VIIa","volume":"405","author":"Larsen","year":"2007","journal-title":"Biochem J"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0125","doi-asserted-by":"crossref","first-page":"15820","DOI":"10.1021\/bi0204544","article-title":"Unusual benefits of macromolecular shielding by polyethylene glycol for reactions at the diffusional limit: the case of factor\u00a0VIIai and tissue factor","volume":"41","author":"Stone","year":"2002","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0130","doi-asserted-by":"crossref","first-page":"923a","DOI":"10.1182\/blood.V110.11.3140.3140","article-title":"Platelet\u2010dependent activity of glycopPEGylated rFVIIa","volume":"110","author":"Sorensen","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.03065.x_bb0135","article-title":"Effect of glycopegylation on the pharmacokinetic properties of FVIIa","volume":"5","author":"Sorensen","year":"2007","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2008.03065.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622132502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622132502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2008.03065.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:46:57Z","timestamp":1761533217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622132502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1538783622132502"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03065.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity and regulation of glycoPEGylated factor\u00a0VIIa analogs","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03065.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}